ACTG Publications

TitleAuthorsDateJournalIssueVolume
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs.John, Mina ; Heckerman, David ; James, Ian ; Park, Lawrence P ; Carlson, Jonathan M ; Chopra, Abha ; Gaudieri, Silvana ; Nolan, David ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Mallal, Simon2010 Apr 15J Immunol8184
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.Amorosa, Valerianna K ; Luetkemeyer, Anne ; Kang, Minhee ; Johnson, Victoria A ; Umbleja, Triin ; Haas, David W ; Yesmin, Suria ; Bardin, Matthew C ; Chung, Ray T ; Alston-Smith, Beverly ; Tebas, Pablo ; Peters, Marion G2013 Nov-DecHIV Clin Trials614
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.Canter, Jeffrey A ; Robbins, Gregory K ; Selph, Doug ; Clifford, David B ; Kallianpur, Asha R ; Shafer, Robert ; Levy, Shawn ; Murdock, Deborah G ; Ritchie, Marylyn D ; Haas, David W ; Hulgan, Todd ; AIDS Clinical Trials Group Study 384 Team ; New Work Concept Sheet 273 Team2010 Jun 1J Infect Dis11201
Antiretroviral concentrations in hair strongly predict virologic response in a large HIV treatment-naive clinical trial.Gandhi, Monica ; Ofokotun, Igho ; Bacchetti, Peter ; Jin, Chengshi ; Ribaudo, Heather J ; Haas, David W ; Sheth, Anandi N ; Horng, Howard ; Phung, Nhi ; Kuncze, Karen ; Okochi, Hideaki ; Landovitz, Raphael J ; Lennox, Jeffrey ; Currier, Judith S ; AIDS Clinical Trials Group (ACTG) 5257 study team2018 Sep 03Clin Infect Dis
Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events.Haas, David W ; Bradford, Yuki ; Verma, Anurag ; Verma, Shefali S ; Eron, Joseph J ; Gulick, Roy M ; Riddler, Sharon A ; Sax, Paul E ; Daar, Eric S ; Morse, Gene D ; Acosta, Edward P ; Ritchie, Marylyn D2018 JulPharmacogenet Genomics728
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.Vardhanabhuti, Saran ; Acosta, Edward P ; Ribaudo, Heather J ; Severe, Patrice ; Lalloo, Umesh ; Kumarasamy, Nagalingeshwaran ; Taulo, Frank ; Kabanda, Joseph ; Oneko, Olola ; Ive, Prudence ; Sambarey, Pradeep ; Chan, Ellen S ; Hitti, Jane ; Hong, Francis ; McMahon, Deborah ; Haas, David W ; A5207 ACTG Study Team2013 Aug 15J Infect Dis4208
Clinical perspectives on human genetic screening to prevent nevirapine toxicity.Haas, David W ; Mootsikapun, Piroon ; Ruxrungtham, Kiat ; Podzamczer, Daniel ; Nevirapine Toxicogenomics Study Team2012 Sep 1Per Med79
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).Gange, Stephen J ; Kitahata, Mari M ; Saag, Michael S ; Bangsberg, David R ; Bosch, Ronald J ; Brooks, John T ; Calzavara, Liviana ; Deeks, Steven G ; Eron, Joseph J ; Gebo, Kelly A ; Gill, M John ; Haas, David W ; Hogg, Robert S ; Horberg, Michael A ; Jacobson, Lisa P ; Justice, Amy C ; Kirk, Gregory D ; Klein, Marina B ; Martin, Jeffrey 2007 AprInt J Epidemiol236
Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.Luetkemeyer, Anne F ; Rosenkranz, Susan L ; Lu, Darlene ; Grinsztejn, Beatriz ; Sanchez, Jorge ; Ssemmanda, Michael ; Sanne, Ian ; McIlleron, Helen ; Havlir, Diane V ; Haas, David W ; Adult AIDS Clinical Trials Group A5221 and A5243 Study Teams2015 Jun 15Clin Infect Dis1260
Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.Schackman, Bruce R ; Haas, David W ; Park, Sanghee S ; Li, X Cynthia ; Freedberg, Kenneth A2015 DecPharmacogenomics1816
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.Hare, C Bradley ; Mellors, John ; Krambrink, Amy ; Su, Zhaohui ; Skiest, Daniel ; Margolis, David M ; Patel, Sheran S ; Barnas, Douglas ; Frenkel, Lisa ; Coombs, Robert W ; Aweeka, Francesca ; Morse, Gene D ; Haas, David W ; Boltz, Valerie ; Palmer, Sarah ; Coffin, John ; Havlir, Diane V2008 Aug 1Clin Infect Dis347
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.Zhang, Xinyan ; Tierney, Camlin ; Albrecht, Mary ; Demeter, Lisa M ; Morse, Gene ; DiFrancesco, Robin ; Dykes, Carrie ; Jiang, Hongyu ; Haas, David W2013 AprTher Drug Monit235
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353.Nyaku, Amesika N ; Zheng, Lu ; Gulick, Roy M ; Olefsky, Maxine ; Berzins, Baiba ; Wallis, Carole L ; Godfrey, Catherine ; Sax, Paul E ; Acosta, Edward P ; Haas, David W ; Smith, Kimberly Y ; Sha, Beverly E ; Van Dam, Cornelius N ; Taiwo, Babafemi O ; ACTG A5353 Study Team2019 Jan 18J Antimicrob Chemother
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.Acosta, Edward P ; Kendall, Michelle A ; Gerber, John G ; Alston-Smith, Beverly ; Koletar, Susan L ; Zolopa, Andrew R ; Agarwala, Sangeeta ; Child, Michael ; Bertz, Richard ; Hosey, Lara ; Haas, David W2007 SepAntimicrob Agents Chemother951
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.Ribaudo, Heather J ; Liu, Huan ; Schwab, Matthias ; Schaeffeler, Elke ; Eichelbaum, Michel ; Motsinger-Reif, Alison A ; Ritchie, Marylyn D ; Zanger, Ulrich M ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David ; Haas, David W2010 Sep 1J Infect Dis5202
Effect of HIV-1 infection on human DNA yield from saliva.Basham, Rebecca J ; Richardson, Danielle M ; Sutcliffe, Cara B ; Haas, David W2009 Jul-AugHIV Clin Trials410
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.Lennox, Jeffrey L ; Landovitz, Raphael J ; Ribaudo, Heather J ; Ofotokun, Ighovwerha ; Na, Lumine H ; Godfrey, Catherine ; Kuritzkes, Daniel R ; Sagar, Manish ; Brown, Todd T ; Cohn, Susan E ; McComsey, Grace A ; Aweeka, Francesca ; Fichtenbaum, Carl J ; Presti, Rachel M ; Koletar, Susan L ; Haas, David W ; Patterson, Kristine B ; Benson, 2014 Oct 7Ann Intern Med7161
European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.Hulgan, Todd ; Haubrich, Richard ; Riddler, Sharon A ; Tebas, Pablo ; Ritchie, Marylyn D ; McComsey, Grace A ; Haas, David W ; Canter, Jeffrey A2011 Jan 2AIDS125
Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.McLaren, Paul J ; Pulit, Sara L ; Gurdasani, Deepti ; Bartha, István ; Shea, Patrick R ; Pomilla, Cristina ; Gupta, Namrata ; Gkrania-Klotsas, Effrossyni ; Young, Elizabeth H ; Bannert, Norbert ; Del Amo, Julia ; Gill, M John ; Gilmour, Jill ; Kellam, Paul ; Kelleher, Anthony D ; Sönnerborg, Anders ; Zangerle, Robert ; Post, Frank A ; Fish2017 11 27J Infect Dis9216
Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression.Li, Binglan ; Verma, Shefali S ; Veturi, Yogasudha C ; Verma, Anurag ; Bradford, Yuki ; Haas, David W ; Ritchie, Marylyn D2018Pac Symp Biocomput23
Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.McLaren, Paul J ; Ripke, Stephan ; Pelak, Kimberly ; Weintrob, Amy C ; Patsopoulos, Nikolaos A ; Jia, Xiaoming ; Erlich, Rachel L ; Lennon, Niall J ; Kadie, Carl M ; Heckerman, David ; Gupta, Namrata ; Haas, David W ; Deeks, Steven G ; Pereyra, Florencia ; Walker, Bruce D ; DE Bakker, Paul I W ; International HIV Controllers Study2012 Oct 1Hum Mol Genet1921
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.Bartha, István ; Carlson, Jonathan M ; Brumme, Chanson J ; McLaren, Paul J ; Brumme, Zabrina L ; John, Mina ; Haas, David W ; Martinez-Picado, Javier ; Dalmau, Judith ; López-Galíndez, Cecilio ; Casado, Concepción ; Rauch, Andri ; Günthard, Huldrych F ; Bernasconi, Enos ; Vernazza, Pietro ; Klimkait, Thomas ; Yerly, Sabine ; O'Brien, Steph2013Elife2
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.Johnson, Daniel H ; Venuto, Charles ; Ritchie, Marylyn D ; Morse, Gene D ; Daar, Eric S ; McLaren, Paul J ; Haas, David W2014 AprPharmacogenet Genomics424
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.Leger, Paul D ; Johnson, Daniel H ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Li, Jun ; McLaren, Paul J ; Haas, David W2014 JunJ Neurovirol320
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.Holzinger, Emily R ; Grady, Benjamin ; Ritchie, Marylyn D ; Ribaudo, Heather J ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David B ; Daar, Eric S ; McLaren, Paul ; Haas, David W2012 DecPharmacogenet Genomics1222
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.Wanga, Valentine ; Venuto, Charles ; Morse, Gene D ; Acosta, Edward P ; Daar, Eric S ; Haas, David W ; Li, Chun ; Shepherd, Bryan E2015 SepPharmacogenet Genomics925
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.Lehmann, David S ; Ribaudo, Heather J ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard H ; Robbins, Gregory K ; DE Bakker, Paul I W ; Haas, David W ; McLaren, Paul J2015 FebPharmacogenet Genomics225
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.Hulgan, Todd ; Tebas, Pablo ; Canter, Jeffrey A ; Mulligan, Kathleen ; Haas, David W ; Dubé, Michael ; Grinspoon, Steven ; Robbins, Gregory K ; Motsinger, Alison A ; Kallianpur, Asha R ; AIDS Clinical Trials Group 384 and A5005s Study Teams2008 Mar 15J Infect Dis6197
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.Kallianpur, Asha R ; Hulgan, Todd ; Canter, Jeffrey A ; Ritchie, Marylyn D ; Haines, Jonathan L ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Haas, David W2006 Jul 13AIDS1120
Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy.Kallianpur, Asha R ; Gerschenson, Mariana ; Hulgan, Todd ; Kaur, Harpreet ; Clifford, David B ; Haas, David W ; Murdock, Deborah G ; McArthur, Justin C ; Samuels, David C ; Simpson, David M2018 NovAIDS Res Hum Retroviruses1134
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.Haas, David W ; Koletar, Susan L ; Laughlin, Laura ; Kendall, Michelle A ; Suckow, Carol ; Gerber, John G ; Zolopa, Andrew R ; Bertz, Richard ; Child, Michael J ; Hosey, Lara ; Alston-Smith, Beverly ; Acosta, Edward P ; A5213 StudyTeam2009 Mar 1J Acquir Immune Defic Syndr350
Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.Lee, Sulggi A ; Mefford, Joel A ; Huang, Yong ; Witte, John S ; Martin, Jeffrey N ; Haas, David W ; McLaren, Paul J ; Mushiroda, Taisei ; Kubo, Michiaki ; Byakwaga, Helen ; Hunt, Peter W ; Kroetz, Deanna L2016 Jul 17AIDS1130
Human genetic variability and HIV treatment response.Haas, David W2006 JulCurr HIV/AIDS Rep23
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.Haas, David W ; Geraghty, Daniel E ; Andersen, Janet ; Mar, Jessica ; Motsinger, Alison A ; D'Aquila, Richard T ; Unutmaz, Derya ; Benson, Constance A ; Ritchie, Marylyn D ; Landay, Alan ; AIDS Clinical Trials Group2006 Oct 15J Infect Dis8194
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.Ribaudo, Heather J ; Daar, Eric S ; Tierney, Camlin ; Morse, Gene D ; Mollan, Katie ; Sax, Paul E ; Fischl, Margaret A ; Collier, Ann C ; Haas, David W ; DS Clinical Trials Group2013 Feb 1J Infect Dis3207
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.Martin, Maureen P ; Naranbhai, Vivek ; Shea, Patrick R ; Qi, Ying ; Ramsuran, Veron ; Vince, Nicolas ; Gao, Xiaojiang ; Thomas, Rasmi ; Brumme, Zabrina L ; Carlson, Jonathan M ; Wolinsky, Steven M ; Goedert, James J ; Walker, Bruce D ; Segal, Florencia P ; Deeks, Steven G ; Haas, David W ; Migueles, Stephen A ; Connors, Mark ; Michael, Nel2018 May 01J Clin Invest5128
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.International HIV Controllers Study ; Pereyra, Florencia ; Jia, Xiaoming ; McLaren, Paul J ; Telenti, Amalio ; DE Bakker, Paul I W ; Walker, Bruce D ; Ripke, Stephan ; Brumme, Chanson J ; Pulit, Sara L ; Carrington, Mary ; Kadie, Carl M ; Carlson, Jonathan M ; Heckerman, David ; Graham, Robert R ; Plenge, Robert M ; Deeks, Steven G ; Giann2010 Dec 10Science6010330
Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation.Hulgan, Todd ; Stein, James H ; Cotter, Bruno R ; Murdock, Deborah G ; Ritchie, Marylyn D ; Dubé, Michael P ; Gerschenson, Mariana ; Haas, David W ; Torriani, Francesca J ; Aids Clinical Trials Group A5152s And Dacs 252 Study Teams2013 OctAIDS Res Hum Retroviruses1029
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.Grady, Benjamin J ; Samuels, David C ; Robbins, Gregory K ; Selph, Doug ; Canter, Jeffrey A ; Pollard, Richard B ; Haas, David W ; Shafer, Robert ; Kalams, Spyros A ; Murdock, Deborah G ; Ritchie, Marylyn D ; Hulgan, Todd ; ACTG 384 and DACS 250 Study Teams2011 Dec 1J Acquir Immune Defic Syndr458
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.Motsinger, Alison A ; Ritchie, Marylyn D ; Shafer, Robert W ; Robbins, Gregory K ; Morse, Gene D ; Labbe, Line ; Wilkinson, Grant R ; Clifford, David B ; D'Aquila, Richard T ; Johnson, Victoria A ; Pollard, Richard B ; Merigan, Thomas C ; Hirsch, Martin S ; Donahue, John P ; Kim, Richard B ; Haas, David W2006 NovPharmacogenet Genomics1116
Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202.Verma, Anurag ; Bradford, Yuki ; Verma, Shefali S ; Pendergrass, Sarah A ; Daar, Eric S ; Venuto, Charles ; Morse, Gene D ; Ritchie, Marylyn D ; Haas, David W2017 MarPharmacogenet Genomics327
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.Dooley, Kelly E ; Savic, Radojka M ; Park, Jeong-Gun ; Cramer, Yoninah ; Hafner, Richard ; Hogg, Evelyn ; Janik, Jennifer ; Marzinke, Mark A ; Patterson, Kristine ; Benson, Constance A ; Hovind, Laura ; Dorman, Susan E ; Haas, David W ; ACTG A5311 Study Team2015Antimicrob Agents Chemother659
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors.Hulgan, Todd ; Donahue, John P ; Smeaton, Laura ; Pu, Minya ; Wang, Hongying ; Lederman, Michael M ; Smith, Kimberly ; Valdez, Hernan ; Pilcher, Christopher ; Haas, David W ; AIDS Clinical Trials Group Study A5138 Team2009 NovEur J Clin Pharmacol1165
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.Hulgan, Todd ; Hughes, Michael ; Sun, Xin ; Smeaton, Laura M ; Terry, Erin ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; McComsey, Grace A ; Canter, Jeffery A ; Morrow, Jason D ; Haas, David W2006 Aug 1J Acquir Immune Defic Syndr442
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.Haas, David W ; Bartlett, John A ; Andersen, Janet W ; Sanne, Ian ; Wilkinson, Grant R ; Hinkle, John ; Rousseau, Franck ; Ingram, Christiana D ; Shaw, Audrey ; Lederman, Michael M ; Kim, Richard B ; Adult AIDS Clinical Trials Group2006 Sep 15Clin Infect Dis643
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.Ribaudo, Heather J ; Haas, David W ; Tierney, Camlin ; Kim, Richard B ; Wilkinson, Grant R ; Gulick, Roy M ; Clifford, David B ; Marzolini, Catia ; Fletcher, Courtney V ; Tashima, Karen T ; Kuritzkes, Daniel R ; Acosta, Edward P ; Adult AIDS Clinical Trials Group Study2006 Feb 1Clin Infect Dis342
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).Castillo-Mancilla, Jose R ; Aquilante, Christina L ; Wempe, Michael F ; Smeaton, Laura M ; Firnhaber, Cynthia ; LaRosa, Alberto M ; Kumarasamy, Nagalingeswaran ; Andrade, Adriana ; Baheti, Gautam ; Fletcher, Courtney V ; Campbell, Thomas B ; Haas, David W ; MaWhinney, Samantha ; Anderson, Peter L2016 JunJ Antimicrob Chemother671
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.Dooley, Kelly E ; Luetkemeyer, Anne F ; Park, Jeong-Gun ; Allen, Reena ; Cramer, Yoninah ; Murray, Stephen ; Sutherland, Deborah ; Aweeka, Francesca ; Koletar, Susan L ; Marzan, Florence ; Bao, Jing ; Savic, Rada ; Haas, David W ; AIDS Clinical Trials Group A5306 Study Team2014 SepAntimicrob Agents Chemother958
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.Moore, Carrie B ; Verma, Anurag ; Pendergrass, Sarah ; Verma, Shefali S ; Johnson, Daniel H ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard ; Robbins, Gregory K ; Ritchie, Marylyn D ; Haas, David W2015 JanOpen Forum Infect Dis12
PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG).Verma, Shefali S ; Frase, Alex T ; Verma, Anurag ; Pendergrass, Sarah A ; Mahony, Shaun ; Haas, David W ; Ritchie, Marylyn D2016Pac Symp Biocomput21
Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.Ferreira, Manuel A R ; Mangino, Massimo ; Brumme, Chanson J ; Zhao, Zhen Zhen ; Medland, Sarah E ; Wright, Margaret J ; Nyholt, Dale R ; Gordon, Scott ; Campbell, Megan ; McEvoy, Brian P ; Henders, Anjali ; Evans, David M ; Lanchbury, Jerry S ; Pereyra, Florencia ; International HIV Controllers Study ; Walker, Bruce D ; Haas, David W ; Sor2010 JanAm J Hum Genet186
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.Mollan, Katie R ; Tierney, Camlin ; Hellwege, Jacklyn N ; Eron, Joseph J ; Hudgens, Michael G ; Gulick, Roy M ; Haubrich, Richard ; Sax, Paul E ; Campbell, Thomas B ; Daar, Eric S ; Robertson, Kevin R ; Ventura, Diana ; Ma, Qing ; Edwards, Digna R Velez ; Haas, David W ; AIDS Clinical Trials Group2017 Sep 01J Infect Dis5216
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.Jacobson, Jeffrey M ; Wang, Hongying ; Bordi, Rebeka ; Zheng, Lu ; Gross, Barry H ; Landay, Alan L ; Spritzler, John ; Routy, Jean-Pierre ; Benson, Constance ; Aberg, Judith ; Tebas, Pablo ; Haas, David W ; Tiu, Jennifer ; Coughlin, Kristine ; Purdue, Lynette ; Sekaly, Rafick-Pierre ; AIDS Clinical Trials Group (ACTG) A5212 Protocol Team2014 Aug 1J Acquir Immune Defic Syndr466
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.Riddler, Sharon A ; Jiang, Hongyu ; Tenorio, Allan ; Huang, Hairong ; Kuritzkes, Daniel R ; Acosta, Edward P ; Landay, Alan ; Bastow, Barbara ; Haas, David W ; Tashima, Karen T ; Jain, Mamta K ; Deeks, Steven G ; Bartlett, John A2007Antivir Ther412
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.Dooley, Kelly E ; Park, Jeong-Gun ; Swindells, Susan ; Allen, Reena ; Haas, David W ; Cramer, Yoninah ; Aweeka, Francesca ; Wiggins, Ilene ; Gupta, Amita ; Lizak, Patricia ; Qasba, Sonia ; van Heeswijk, Rolf ; Flexner, Charles ; ACTG 5267 Study Team2012 Apr 15J Acquir Immune Defic Syndr559
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.Vardhanabhuti, Saran ; Ribaudo, Heather J ; Landovitz, Raphael J ; Ofotokun, Ighovwerha ; Lennox, Jeffrey L ; Currier, Judith S ; Olson, Lana M ; Haas, David W2015 SepOpen Forum Infect Dis32
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.Haas, David W ; Kwara, Awewura ; Richardson, Danielle M ; Baker, Paxton ; Papageorgiou, Ioannis ; Acosta, Edward P ; Morse, Gene D ; Court, Michael H2014 AugJ Antimicrob Chemother869
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.Hulgan, Todd ; Robbins, Gregory K ; Kalams, Spyros A ; Samuels, David C ; Grady, Benjamin ; Shafer, Robert ; Murdock, Deborah G ; Selph, Doug ; Haas, David W ; Pollard, Richard B ; AIDS Clinical Trials Group2012PLoS One87
Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.Almeida, Coral-Ann M ; Bronke, Corine ; Roberts, Steven G ; McKinnon, Elizabeth ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Carlson, Jonathan ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Heckerman, David ; Mallal, Simon ; John, Mina2011 Sep 1J Immunol5187
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants.Grady, Benjamin J ; Torstenson, Eric S ; McLaren, Paul J ; DE Bakker, Paul I W ; Haas, David W ; Robbins, Gregory K ; Gulick, Roy M ; Haubrich, Richard ; Ribaudo, Heather ; Ritchie, Marylyn D2011Pac Symp Biocomput